X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
23
PharmaCompass offers a list of Rilpivirine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Rilpivirine Hydrochloride manufacturer or Rilpivirine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rilpivirine Hydrochloride manufacturer or Rilpivirine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Rilpivirine Hydrochloride API Price utilized in the formulation of products. Rilpivirine Hydrochloride API Price is not always fixed or binding as the Rilpivirine Hydrochloride Price is obtained through a variety of data sources. The Rilpivirine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Rilpivirine HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rilpivirine HCl, including repackagers and relabelers. The FDA regulates Rilpivirine HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rilpivirine HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Rilpivirine HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Rilpivirine HCl supplier is an individual or a company that provides Rilpivirine HCl active pharmaceutical ingredient (API) or Rilpivirine HCl finished formulations upon request. The Rilpivirine HCl suppliers may include Rilpivirine HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Rilpivirine HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Rilpivirine HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Rilpivirine HCl active pharmaceutical ingredient (API) in detail. Different forms of Rilpivirine HCl DMFs exist exist since differing nations have different regulations, such as Rilpivirine HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Rilpivirine HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Rilpivirine HCl USDMF includes data on Rilpivirine HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Rilpivirine HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Rilpivirine HCl suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Rilpivirine HCl Drug Master File in Japan (Rilpivirine HCl JDMF) empowers Rilpivirine HCl API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Rilpivirine HCl JDMF during the approval evaluation for pharmaceutical products. At the time of Rilpivirine HCl JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Rilpivirine HCl suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Rilpivirine HCl Drug Master File in Korea (Rilpivirine HCl KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Rilpivirine HCl. The MFDS reviews the Rilpivirine HCl KDMF as part of the drug registration process and uses the information provided in the Rilpivirine HCl KDMF to evaluate the safety and efficacy of the drug.
After submitting a Rilpivirine HCl KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Rilpivirine HCl API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Rilpivirine HCl suppliers with KDMF on PharmaCompass.
A Rilpivirine HCl written confirmation (Rilpivirine HCl WC) is an official document issued by a regulatory agency to a Rilpivirine HCl manufacturer, verifying that the manufacturing facility of a Rilpivirine HCl active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Rilpivirine HCl APIs or Rilpivirine HCl finished pharmaceutical products to another nation, regulatory agencies frequently require a Rilpivirine HCl WC (written confirmation) as part of the regulatory process.
click here to find a list of Rilpivirine HCl suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Rilpivirine HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Rilpivirine HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Rilpivirine HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Rilpivirine HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Rilpivirine HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Rilpivirine HCl suppliers with NDC on PharmaCompass.
Rilpivirine HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Rilpivirine HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Rilpivirine HCl GMP manufacturer or Rilpivirine HCl GMP API supplier for your needs.
A Rilpivirine HCl CoA (Certificate of Analysis) is a formal document that attests to Rilpivirine HCl's compliance with Rilpivirine HCl specifications and serves as a tool for batch-level quality control.
Rilpivirine HCl CoA mostly includes findings from lab analyses of a specific batch. For each Rilpivirine HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Rilpivirine HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Rilpivirine HCl EP), Rilpivirine HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rilpivirine HCl USP).
Market Place
